China Tian Yuan Healthcare : Further Delay in Dispatch of Circular in relation to the Major and Connected Transaction - Disposal of 51% Equity Interest in a Subsidiary

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA TIAN YUAN HEALTHCARE GROUP LIMITED

中國天元醫療集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 557)

FURTHER DELAY IN DISPATCH OF CIRCULAR

IN RELATION TO THE MAJOR AND CONNECTED TRANSACTION -

DISPOSAL OF 51% EQUITY INTEREST IN A SUBSIDIARY

References are made to the announcements of the Company dated 26 June 2019, 28 June 2019 and 6 July 2019 in relation to the major and connected transaction of disposal of 51% equity interest in a subsidiary (the "Announcements") and announcements of the Company dated 18 July 2019, 9 August 2019 and 6 September 2019 in relation to the delay in dispatch of the Circular (the "Delay in Dispatch Announcements"). Unless otherwise stated, capitalised terms used herein shall have the same meanings as those defined in the Announcements and the Delay in Dispatch Announcements.

As disclosed in the Delay in Dispatch Announcements, the expected dispatch date of the Circular was postponed to a date falling on or before 30 September 2019. Since additional time is required to prepare and finalise certain information to be included in the Circular, it is expected that the dispatch date of the Circular will be further postponed to a date falling on or before 31 October 2019.

By order of the Board

China Tian Yuan Healthcare Group Limited

Jiang Yulin

Chairman

Hong Kong, 30 September 2019

As at the date of this announcement, the Board is composed of eight directors of which Mr. Jiang Yulin (chairman) and Ms. Zhang Xian are the executive directors, Ms. He Mei, Mr. Zhang Yupeng and Mr. Zhou Yuan are the non-executive directors and Mr. Hu Baihe, Mr. Yuen Kwok Kuen and Mr. Guo Jingbin are the independent non-executive directors.